OR WAIT null SECS
June 05, 2008
Also, Pall plans expansion in South America, Anthony Clarke joins Alexza Pharmaceuticals, more...
The US Food and Drug Administration advised patients, caregivers, and healthcare professionals to switch to hydrofluoroalkane-propelled albuterol inhalers now because chlorofluorocarbon-propelled inhalers will not be available in the US after Dec. 31, 2008.
June 02, 2008
Nanoparticle-based systems present many advantages for the delivery of current and emerging biological drugs.
Letting the public inside the drug development process may increase their faith in what we do.
Although the spotlight is now on nanoparticulate delivery for biologicals, other strategies have proven successful.
The good, the bad, and the ugly about direct-to-consumer advertising.
May 29, 2008
University of Calgary biochemists used computer simulation in a new toxicity study to predict how "buckyballs," carbon-60 soccer ball-shaped nanomolecules, could damage animal cells.
Also, GVK BIO and Wyeth Pharmaceuticals form research agreement, Eli Lilly announces changes to management, more...
May 20, 2008
Cambridge Consultants is developing a low-cost portable instrument to test respiratory drug-delivery devices.
Also, Pfizer to close Indiana "Exubera" facility, executive appointments at Patheon, more...